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patients undergoing hematopoietic stem cell
transplantation
Sameeh S Ghazal1,2*, Michael P Stevens1, Gonzalo M Bearman1 and Michael B Edmond1
Abstract
Background: Surveillance blood cultures are often obtained in hematopoietic stem cell transplant (HSCT) patients
for detection of bloodstream infection. The major aims of this retrospective cohort study were to determine the
utility of the practice of obtaining surveillance blood cultures from asymptomatic patients during the first 100 post-
transplant days and to determine if obtaining more than one positive blood culture helps in the diagnosis of
bloodstream infection.
Methods: We conducted a 17-month retrospective analysis of all blood cultures obtained for patients admitted to
the hospital for HSCT from January 2010 to June 2011. Each patient’s clinical course, vital signs, diagnostic testing,
treatment, and response to treatment were reviewed. The association between number of positive blood cultures
and the final diagnosis was analyzed.
Results: Blood culture results for 205 patients were reviewed. Cultures obtained when symptoms of infection were
present (clinical cultures) accounted for 1,033 culture sets, whereas 2,474 culture sets were classified as surveillance
cultures (no symptoms of infection were present). The total number of positive blood cultures was 185 sets (5.3%
of cultures obtained) and accounted for 84 positive culture episodes. Incidence of infection in autologous, related
allogeneic and unrelated allogeneic transplants was 8.3%, 20.0%, and 28.6% respectively. Coagulase-negative
staphylococci were the most common organisms isolated. Based on our application of predefined criteria there
were 29 infections and 55 episodes of positive blood cultures that were not infections. None of the patients who
developed infection were diagnosed by surveillance blood cultures. None of the uninfected patients with positive
blood cultures showed any clinical changes after receiving antibiotics. There was a significant difference between
the incidence of BSI in the first and second 50-day periods post-HSCT. There was no association between the
number of positive blood cultures and the final diagnosis.
Conclusion: Surveillance blood cultures in patients who have undergone HSCT do not identify bloodstream
infections. The number of positive blood cultures was not helpful in determining which patients had infection.
Patients are at higher risk of infection in the first 50 days post-transplant period.
Introduction
Bloodstream infection (BSI) remains a significant com-
plication following hematopoietic stem cell transplant-
ation (HSCT), with post-transplant BSI occurring in 12.5
to 41% of patients [1-8]. Antimicrobial prophylaxis and
corticosteroid therapy may make it more difficult to
diagnose BSI in patients with HSCT as the yield of blood
cultures in patients who are already on antibiotics is lim-
ited [9-11] and corticosteroids may mask the signs of in-
flammation [12]. For these reasons, some experts have
recommended surveillance blood cultures to detect oc-
cult bacteremia [12]. Previous studies regarding the util-
ity of surveillance blood cultures in patients undergoing
hematopoietic stem cell transplantation (HSCT) are
scarce with small numbers of patients, and describe spe-
cific subgroups of patients in relation to the type of
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transplant or the patients’ age [13-17]. Moreover, these
studies have come to differing conclusions [10-13].
The primary objective of this study was to investigate
whether surveillance blood cultures (performed weekly
per our hospital protocol) are valuable in the early diag-
nosis of BSI during the first 100 days post-transplant.
Secondary objectives were: to determine whether the fre-
quency of infection differs between the first 50 days
post-transplant and the second 50 days and to identify
the relevance of the number of positive cultures sets in
the diagnosis of bloodstream infection.
Methods
A retrospective cohort study was performed at an 820-
bed academic medical center in an attempt to under-
stand why high rates of contaminated blood cultures
were observed in the HSCT population. Since this pro-
ject was considered to be a quality improvement study,
institutional review board approval was not obtained.
Permission was received from the hospital to use the pa-
tient data for this report.
Using the BMT unit log book all patients who under-
went HSCT in the 17-month period between January 1,
2010 and May 31, 2011 were identified. Electronic med-
ical records of these patients were reviewed and all
blood culture results identified. Standard practice was to
obtain all blood samples for blood cultures from central
lines; obtaining concomitant blood samples from a per-
ipheral vein was not routinely performed.
Each patient’s clinical course, vital signs, diagnostic test-
ing, treatment, and response to treatment were reviewed
for one week before the date of each positive blood culture
until discontinuation of antibiotics (if given), hospital dis-
charge or death. Findings were tabulated and evaluated
against clinical diagnostic criteria established a priori.
Definitions
Blood cultures
A surveillance blood culture was defined as a blood cul-
ture done at a regular interval of at least 5 days (weekly
as per our hospital protocol or 5 days if the screening
culture due time is on the weekend) in the absence of
clinical features of infection (fever, hypotension, or mal-
aise). A clinical blood culture was defined as a blood cul-
ture done in the presence of systemic symptoms of
infection (fever, hypotension, and/or malaise) and/or a
blood culture obtained <5 days after a previous blood
culture as the surveillance blood culture definition re-
quired a 7-day interval between cultures (5 days if due
on the weekend).
Outcomes
Each positive blood culture was evaluated and a deter-
mination made as to whether it represented infection or
not. With absence of a gold standard for the clinical
diagnosis of catheter-related bloodstream infection, we
utilized the CDC criterion: the patient has at least one of
the following signs or symptoms: fever (>38°C), chills, or
hypotension, and the signs and symptoms and positive
laboratory results are not related to an infection at an-
other site. Bloodstream infection was defined as one or
more positive blood cultures obtained in the presence of
clinical features with systemic antibiotics administered
for more than 5 days [4,6,9,10]. Uninfected patients were
defined as those who had one or more positive blood
cultures but no clinical features of infection. A positive
culture episode was defined as one positive blood cul-
ture set or group of successive positive blood cultures
sets all done within one week, irrespective of their num-
ber or whether the patient was classified as infected or
not. Clinical features were defined as fever (temperature
>38°C), and/or hypotension (systolic blood pressure less
than 90 mm Hg or diastolic less than 60 mm Hg), and/
or malaise.
Statistical methodology
Proportion of positive cultures was compared using the
Chi square test or Fisher’s exact test when appropriate.
The one-sample proportion t-test was used to compare
proportions of infections in the first and last 50 days fol-
low up period. The level of significance (α) was set at
0.05. SAS software was used for all statistical analyses.
Results
The number of patients who underwent HSCT during
the study period was 213. Data could not be retrieved
for 8 patients; therefore the medical records of 205 pa-
tients were reviewed. For these patients, the total num-
ber of blood cultures obtained was 3,507 culture sets
(mean 17 cultures per patient; range 1–60). Clinical cul-
tures accounted for 1,033 cultures and 2,474 were classi-
fied as surveillance cultures. The total number of
positive blood cultures was 158 (4.5% of cultures ob-
tained) and accounted for 84 positive culture episodes.
The incidence of bloodstream infection in autologous,
related allogeneic and unrelated allogeneic transplants
was 8.3%, 20.0%, and 28.6% respectively (Table 1).
Table 1 Incidence of bloodstream infection in relation to
type of HSCT
Type of HSCT Infection No
infection
Patients Incidence
of infection
Autologous 11 9 133 8.3%
Allogeneic (related) 6 21 30 20.0%
Allogeneic (unrelated) 12 25 42 28.6%
Total 29 55 205 14.1%
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None of the patients who developed bloodstream in-
fection were diagnosed by surveillance blood cultures.
Based on our predefined criteria there were 29 infections
and 55 episodes of positive blood cultures that were not
infections. All patients in the infection group and 21 pa-
tients in the non-infection group received systemic anti-
biotics for at least 10 days per episode. None of the 21
uninfected patients had symptoms before the surveil-
lance culture or showed any clinical changes after re-
ceiving antibiotics. The majority of infections [21/29
(72%)] occurred in the first 50 days post-transplant (p =
0.008), and nearly half occurred in the first 20 days
(Figure 1).
The most common organisms isolated were coagulase-
negative staphylococci, 41/84 (49%) in pure culture and
an additional 10 (12%) in mixed cultures. Klebsiella spp.
and enterococci each accounted for 5 episodes (6%) of
positive cultures; viridans group streptococci accounted
for 2 episodes (2.4%); and the remaining 25% were
caused by different organisms each occurring only once
(Table 2).
The clinical feature most common in infected patients
was fever (22/29 [41%]); malaise occurred in 12/29, and
hypotension in 3/29 infections. Some patients had
combinations of the above three signs and symptoms. Im-
portantly, none of the 29 patients with the final diagnosis
of infection were diagnosed by surveillance cultures.
BSIs were more frequent in the first 50 days following
transplant (p = 0.008). There was no statistically significant
difference between the proportion of BSIs diagnosed by
one positive blood culture or more than one positive
blood culture (p = 0.40). This was also true for the subset
of BSIs due to coagulase-negative staphylococci (Tables 3
and 4).
Discussion
BSI occurred in 14.1% of our patients, which is near the
lower limits of the previously published rates (12.5-40%)
[1-8]. Patients undergoing unrelated allogeneic HSCT
had the highest incidence of infection (29%), followed by
related allogeneic HSCT (20%), and lowest in autologous
HSCT (8%).
Studies addressing the utility of surveillance blood cul-
tures in HSCT patients are few, even though perform-
ance of surveillance blood cultures is standard practice
at many centers. In non-immunosuppressed patients,
surveillance cultures are not performed since nearly all
positive cultures will represent either contamination, or
in the case of cultures drawn through indwelling central
venous lines, colonization of the catheter lumen. On
reviewing the medical records of our 205 HSCT patients
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Figure 1 Timeline of infections.
Table 2 Organisms detected in 84 positive blood
culture episodes
Organism Diagnosis Total
Infection Non-infection
Coagulase-negative
staphylococci
12 (41%) 29 (52.7%) 41 (48.8%)
Mixed (any two organisms) 03 (10%) 07 (12.7%) 10 (11.9%)
Klebsiella spp 03 (10%) 02 (03.6%) 5 (6.0%)
Enterococci 03 (10%) 02 (03.6%) 5 (6.0%)
Viridans group streptococci 00 02 (03.6%) 2 (2.4%)
Other 08* (28%) 13+ (23.6%) 21 (25.0%)
Total 29 (100%) 55 (100%) 84 (100.0%)
*Include one Yeast.
+Include two Candida species.
Table 3 Number of positive blood culture sets in infection
and non-infection episodes (all organisms)
Number of positive blood
cultures
Diagnosis 1 >1 Total
Infection 23 (79.3%) 6 (20.7%) 29
No Infection
(contamination/colonization)
39 (70.9%) 16 (29.1%) 55
Total 62 (83.8%) 22 (16.2%) 84
P = 0.40.
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with predefined diagnostic criteria, we found that sur-
veillance blood cultures did not detect a single case of
BSI. Thus, the performance of surveillance blood cul-
tures resulted in over diagnosis and subsequent treat-
ment for 21 patients in our cohort. This drives the
overuse of antibiotics, which may result in increasing
rates of antibiotic resistance, increased cost, and poten-
tial complications such as Clostridium difficile infection.
Chizuka et al. [13] described 15 of 25 (60%) patients
on corticosteroid therapy following allogenic HSCT that
had definitive bloodstream infection without fever at the
time of diagnosis; moreover, 4 of them remained afebrile
during the course of infection. Diagnostic criteria for
bloodstream infection in this paper were the presence of
2 positive blood cultures for common skin contaminants
or one positive culture for other pathogens, but clinical
findings were not included as part of the diagnostic cri-
teria. This might lead to misclassifying colonized central
lines as BSI (i.e., over diagnosis). Frere et al. [14] con-
cluded that routine surveillance cultures predicted
bacteremia in their cohort of 505 HSCT patients;
however, there was no clear case definition for BSI.
Moreover, they refer as well to their finding that for
coagulase-negative staphylococci, the predictive value of
surveillance cultures is quite low because of the very
high rate of central venous line colonization observed in
their patients (77%). They also found that routine surveil-
lance blood cultures were unable to detect bacteremia
with streptococci and anaerobes.
Penack et al. [15] detected microbial growth prior to
the onset of infection symptoms in 3 of 45 neutropenic
episodes in 39 patients that led to modifications in pa-
tient management, but they did not describe their case
definition. They noted that shortly after starting antibi-
otics, the three patients showed signs of infection; thus,
it is possible that the blood cultures detected line
colonization that preceded infection. Rigby et al. [16] re-
ported that 3 of 43 positive blood cultures in neutro-
penic children which yielded organisms, when repeated
prior to starting antibiotics were sterile, suggesting that
these positive cultures represented colonization rather
than infection. Czirok et al. [17] found that in 14
episodes of fever in 23 HSCT patients, surveillance cul-
tures yielded bacteria identical with those in clinical
blood cultures in only one episode and in the remaining
three documented BSIs the identified bacteria isolated
by surveillance cultures was not the same as the bacteria
identified by clinical blood cultures. They concluded that
surveillance blood cultures were of limited value in pre-
dicting infection. Neither this study nor any one of the
studies mentioned above utilized differential time to
positivity as did Abdelkafi et al. [18], who found that
marker was associated with 86% sensitivity and 87% spe-
cificity. Thus it seems that surveillance blood cultures
result in identification of central line colonization status,
which does not require treatment.
We found that bloodstream infections were more fre-
quent in the early post-transplant period. We also found
that there was no statistically significant difference be-
tween BSI diagnosed by one positive blood culture or
more than one positive blood culture, and this implies
that the current CDC surveillance definition for central
line associated bloodstream infection that requires at
least two positive blood cultures for common skin con-
taminants such as coagulase-negative staphylococci may
not be useful in this patient population and should be
further evaluated in other studies.
The strengths of our study are the relatively large
number of patients evaluated (205), and the inclusion of
patients of all age groups and all types of HSCT. A
weakness of the study is that it was performed at a single
center and there may be local institutional practices that
could limit the generalizability of our results. In addi-
tion, retrospective review of clinical records for symp-
toms of infection could have resulted in misclassification
of infected patients as uninfected, though including
vital signs in the definition, which were consistently
recorded for these patients, should limit the degree of
misclassification.
Conclusions
Patients undergoing HSCT are at a high risk of blood-
stream infection, especially those patients undergoing un-
related allogeneic transplantation, and coagulase-negative
staphylococci were the most common cause. We demon-
strate that post-HSCT surveillance blood cultures are not
useful for the early detection of bacteremia and likely re-
sult in increased cost and unnecessary use of antibiotics.
Post-HSCT patients have higher risk of infection during
the first 50 days post-transplant. Lastly, the number of
positive blood cultures was not useful in the determin-
ation of infection in these patients.
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Table 4 Number of positive blood culture sets in infection
and non-infection episodes due to coagulase-negative
staphylococci
Number of positive blood
cultures
Diagnosis 1 >1 Total
Infection 12 (100.0%) 0 (0.0%) 12 (100%)
No infection
(contamination/colonization)
26 (89.7%) 3 (10.3%) 29 (100%)
Total 38 3 41
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